John E Kao $ALHC SEC Form 4 Insider Trading

John E Kao has filed a total of 42 insider trades in $ALHC since 2021. Their most recent trade was a sale of 90,000 shares, made on Apr 14, 2025. Their largest trade was a sale of 554,713 shares, made on Mar 06, 2025. We estimate that they now own 6.9 million shares of $ALHC, worth an estimated $127.2 million.

Insider Trading at $ALHC

There have been a total of 265 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 51.8 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 230,000 shares reported by Dawn Christine Maroney (President), made on Apr 14, 2025.

$ALHC Executives and Stock Owners with Insider Trades

• Robert Thomas Freeman, Chief Financial Officer

• John E Kao, Chief Executive Officer

• Dawn Christine Maroney, President, Markets

• Dinesh M. Kumar, Chief Med & Operating Officer

• Christopher J Joyce, Chief Legal and Admin. Officer

• Hakan Kardes, Chief Experience Officer

• Dawn Christine Maroney, President

• Hyong Kim, Chief Medical Officer

• Robert L. Scavo, Chief Information Officer

• Andreas P. Wagner, Chief Human Resources Officer

• Dinesh M. Kumar, Chief Medical Officer

• Joseph S Konowiecki, Chairman of the Board

• Richard A. Cross, SVP, General Counsel

• Sebastian Burzacchi, COO - Mgmt Services Org

• Donald Steven Furman, Chief Clinical Officer

• Rajesh Shrestha, Pres., New Markets & CBO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.